Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02158403 · ClinicalTrials.gov registry record · NA
PREVENtion of HeartMate II Pump Thrombosis
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT02158403 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 300 participants.
The verdict
NCT02158403, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to assess how often blood clots form in the FDA-approved HeartMate® II (HM II) Left Ventricular Assist Device (LVAD) and to identify risks related to clotting within the pump.
Interventions
- OTHER Clinical Management Recommendations for reducing pump thrombosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2014-09 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02158403
The ClinicalTrials.gov registry entry for NCT02158403 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Clinical Management Recommendations for reducing pump thrombosis is the first listed.
NCT02158403 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02158403 about?
NCT02158403 is a clinical study titled "PREVENtion of HeartMate II Pump Thrombosis". The purpose of this study is to assess how often blood clots form in the FDA-approved HeartMate® II (HM II) Left Ventricular Assist Device (LVAD) and to identify risks related to clotting within the pump.
What is the current status of trial NCT02158403?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2014-09. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02158403?
The interventions under investigation include: Clinical Management Recommendations for reducing pump thrombosis (OTHER).
Who is sponsoring clinical trial NCT02158403?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.